Search by Drug Name or NDC

    NDC 00173-0135-55 WELLBUTRIN 150 mg/1 Details

    WELLBUTRIN 150 mg/1

    WELLBUTRIN is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is BUPROPION HYDROCHLORIDE.

    Product Information

    NDC 00173-0135
    Product ID 0173-0135_d3423427-a8fe-473b-ae18-305040d648b8
    Associated GPIs 58300040107430
    GCN Sequence Number 046238
    GCN Sequence Number Description bupropion HCl TAB SR 12H 150 MG ORAL
    HIC3 H7D
    HIC3 Description NOREPINEPHRINE AND DOPAMINE REUPTAKE INHIB (NDRIS)
    GCN 16386
    HICL Sequence Number 001653
    HICL Sequence Number Description BUPROPION HCL
    Brand/Generic Brand
    Proprietary Name WELLBUTRIN
    Proprietary Name Suffix SR
    Non-Proprietary Name bupropion hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name BUPROPION HYDROCHLORIDE
    Labeler Name GlaxoSmithKline LLC
    Pharmaceutical Class Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA020358
    Listing Certified Through 2024-12-31

    Package

    NDC 00173-0135-55 (00173013555)

    NDC Package Code 0173-0135-55
    Billing NDC 00173013555
    Package 60 TABLET, FILM COATED in 1 BOTTLE (0173-0135-55)
    Marketing Start Date 1996-11-15
    NDC Exclude Flag N
    Pricing Information N/A